Actively Recruiting
Examining the Effect of Action Observation Training Using Patient-Specific 3D Records in Parkinson's Patients
Led by Abant Izzet Baysal University · Updated on 2026-05-11
24
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the effects of action observation training in people with Parkinson's disease, focusing on improving bradykinesia, which is a slowing of movement. This study aims to use each patient's own 3D motion recordings delivered through an immersive virtual reality (VR) environment to see how this personalized training impacts movement speed and other disease-related measures. The study builds on evidence that observing rhythmic actions can influence motor performance and that immersive VR may enhance brain response compared to traditional screen-based methods. Participants will be randomly assigned to one of two groups: one group will receive VR action observation training using their own 3D motion recordings, while the other group will watch VR recordings of healthy individuals performing the same movements. Training involves watching five one-minute tasks involving hand and arm movements, with one-minute rests between each task. This training will be provided alongside conventional therapy tailored to individual needs, lasting 35 minutes, three times a week for six weeks. During the study, participants will be assessed at the start and after the six-week intervention. Measurements include the spontaneous movement rate, Parkinson's disease rating scales, hand function tests, questionnaires about arm and hand disabilities, quality of life, and motivation. Researchers will monitor participants' progress and safety throughout the study, which lasts six weeks, with the main focus on changes in movement speed and other functional outcomes.
CONDITIONS
Brief Title
Patient-Specific 3D Action Observation Training in Parkinson's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Voluntary agreement to participate in the study
- Clinical diagnosis of Parkinson's disease confirmed by a neurologist
- Ongoing treatment with antiparkinsonian medication
- Hoehn and Yahr (H-Y) stage �3 3
- Ability to walk independently
- Age between 50 and 85 years
You will not qualify if you...
- Presence of additional neurological disorders other than Parkinson's disease
- Change in medication dosage within the past month
- Score of �3 10 on the Simulator Sickness Questionnaire
- Presence of amblyopia, strabismus, or pathologies impairing focus, depth perception, or normal 3D vision
- Failure on the butterfly test of the Titmus stereotest (greater than 3,552 seconds of arc)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 weeks
Participants receive immersive VR action observation training using either their own 3D motion recordings or recordings from healthy individuals. Training consists of 35-minute sessions, 3 days per week for 6 weeks, provided in addition to conventional therapy tailored to individual needs.
Up to 18 visits (3 times per week for 6 weeks)
Trial Site Locations
Total: 1 location
1
Abant Izzet Baysal University Faculty of Health Science
Bolu, Bolu, Turkey (Türkiye), 14100
Actively Recruiting
Research Team
E
Enes T Benli, Ph.D
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here